Understanding acute hepatitis B serology

No single marker tells the entire story. Clinicians interpret the surface antigen, core antibodies and surface antibody together, alongside symptoms, liver tests, exposure timing and sometimes a test that measures viral genetic material.

Hepatitis B surface antigen indicates that viral material is currently present. IgM antibody to the hepatitis B core antigen supports a recent infection, while total core antibody shows current or past natural exposure. Surface antibody can reflect recovery and immunity or vaccination, depending on whether core antibody is also present.

Early infection, recovery and the transition between them can create changing or incomplete patterns. A result marked reactive is therefore interpreted in context rather than labelled acute infection in isolation. Repeat testing may clarify whether surface antigen clears and surface antibody develops.

Arrange a clinical review rather than trying to interpret an isolated result. Bring the full laboratory report, dates of possible exposure, vaccination history, symptoms and any earlier hepatitis results. The clinician may repeat serology, assess liver inflammation and check viral activity.

Until your status is clear, do not donate blood and avoid sharing razors, toothbrushes or injection equipment. Cover open cuts and use barrier protection during sex. Household and sexual contacts should seek advice about testing and vaccination. Hepatitis B does not spread through ordinary contact such as hugging or sharing a room.

Seek emergency care for confusion, marked drowsiness, collapse, vomiting blood, black stools or unusual bleeding. These features may signal severe liver dysfunction and should not wait for a routine serology appointment.

Request prompt assessment for persistent vomiting, inability to keep fluids down, severe upper abdominal pain, yellow skin or eyes, dark urine or rapidly worsening weakness. Mention pregnancy, immune suppression or existing liver disease because these factors affect evaluation and follow-up.

Ask which markers were reactive, whether the pattern fits recent infection, vaccination or past exposure, and when repeat testing is due. Clarify which contacts need testing or vaccination and which medicines or supplements to avoid while liver results are abnormal.